|
|
|
12 Mar 2010 |
Baxter Presents Clinical Efficacy Results from Phase III Study of Seasonal Flu Vaccine
|
34 |
|
11 Mar 2010 |
BioSante Announces Positive Leukemia Vaccine Results
|
42 |
|
10 Mar 2010 |
ImmunoCellular Therapeutics’ Dendritic Cell-Based Vaccine Demonstrates Statistically Significant Increase in Survival in an Animal Model of Glioblastoma
|
45 |
|
09 Mar 2010 |
Bavarian Nordic Successfully Completes End of Phase II Meeting for PROSTVAC
|
24 |
|
08 Mar 2010 |
Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis™ Personalized Immunotherapy Platform in Metastatic RCC at ASCO GU Symposium
|
80 |
|
04 Mar 2010 |
Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
|
71 |
|
04 Mar 2010 |
BioVex Initiates Phase 1 Clinical Trial with Its Genital Herpes Vaccine, ImmunoVEXHSV2
|
130 |
|
03 Mar 2010 |
Merck Reports Results of Phase III Study of Investigational Oral Allergy Immunotherapy Tablet (AIT) in Patients Ages 5-17 with Grass Pollen Allergy
|
84 |
|
25 Feb 2010 |
AFFiRiS AG: vaccination against hypertension is development project no. 4 and has already been awarded an FFG grant of up to 1.2 million.
|
129 |
|
24 Feb 2010 |
Pfizer Receives FDA Approval for Prevnar 13 for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
|
74 |
|
24 Feb 2010 |
Publication of Vical's H5N1 Results Paves the Way for H1N1 Clinical Trial
|
56 |
|
23 Feb 2010 |
GlycoVaxyn's First Clinical Study with Bioconjugate Vaccine Initiated
|
80 |
|
22 Feb 2010 |
Cyto Pulse, the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers
|
81 |
|
22 Feb 2010 |
CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
|
66 |
|
22 Feb 2010 |
Novartis receives FDA approval of Menveo®, a vaccine to prevent meningococcal disease
|
73 |
|
19 Feb 2010 |
Sanofi Pasteur’s A(H1N1) Vaccine Humenza Recommended by European Medicines Agency
|
96 |
|
19 Feb 2010 |
NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
|
71 |
|
18 Feb 2010 |
GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
|
53 |
|
18 Feb 2010 |
VIRxSYS Announces at CROI Promising Results from Its HIV Vaccine Study
|
69 |
|
17 Feb 2010 |
Immune Targeting Systems (ITS) Ltd. Secures an GBP 8.65 mln Series A Extension to Fund FP-01, Its Synthetic Universal Flu Vaccine Through Phase-II Studies
|
93 |
|
17 Feb 2010 |
In Phase III Data Merck's GARDASIL® Was Efficacious Against Anal Disease Caused by HPV 6,11,16, and 18
|
84 |
|
12 Feb 2010 |
Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine
|
94 |
|
11 Feb 2010 |
Intercell obtains results from its first Phase I investigational vaccine study for Streptococcus pneumoniae
|
69 |
|
10 Feb 2010 |
Cancer Research UK to Fund Clinical Trial of ADXS11-001 for the Treatment of Head and Neck Cancer
|
75 |
|
08 Feb 2010 |
NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
|
61 |
|
08 Feb 2010 |
Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate
|
63 |
|
08 Feb 2010 |
Nabi Biopharmaceuticals Completes Another PentaStaph(TM) Milestone
|
66 |
|
08 Feb 2010 |
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
|
75 |
|
08 Feb 2010 |
Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
|
59 |
|
02 Feb 2010 |
Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
|
193 |
| |
|
Results 1 - 30 of 979 |
